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Background: It is well established that the amygdala is crucially involved in the processing of facial emotions. In
schizophrenia patients, a number of neuroimaging findings suggest hypoactivation of the amygdala in response to
facial emotion, while others indicate normal or enhanced recruitment of this region. Some of this variability may be
related to the baseline condition used and the length of the experiment. There is evidence that schizophrenia
patients display increased activation of the amygdala to neutral faces and that this is predominantly observed
during early parts of the experiment. Recent research examining the automatic processing of facial emotion has
also reported amygdala hyperactivation in schizophrenia. In the present study, we focused on the time-course of
amygdala activation during the automatic processing of emotional facial expression. We hypothesized that in
comparison to healthy subjects, patients would initially show hyperresponsivity of the amygdala to masked
emotional and neutral faces. In addition, we expected amygdala deactivation in response to masked facial emotions
from the first to the second phase to be more pronounced in patients than in controls.
Results: Amygdala activation in response to angry, happy, neutral, and no facial expression (presented for 33 ms)
was measured by functional magnetic resonance imaging in 30 schizophrenia patients and 35 healthy controls.
Across all subjects, the bilateral amygdala response to faces (relative to the no facial expression condition) was
larger in the initial phase (first half of trials) than in the second phase (second half of trials). During the initial phase,
schizophrenia patients exhibited an increased right amygdala response to all faces and an increased left amygdala
response to neutral faces compared with controls. During the second phase, controls manifested a higher right
amygdala response for all faces and a higher left amygdala response to angry faces than patients.
Conclusions: Schizophrenia patients are characterized by high initial amygdala responsivity to facial expressions at
an automatic processing level, which substantially decreases with time. Amygdala deactivation over time might
reflect an automatic mechanism by which schizophrenia patients suppress the processing of facial stimuli. This
blocking mechanism could help patients avoid overstimulation during social interactions.
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Over the last few decades, many studies have reported ab-
normalities in the processing of facial emotions in schizo-
phrenia patients. Most studies find that patients show
significant deficits in facial affect recognition [1], which
may be related to poor social functioning [2]. With respect
to the neural underpinnings of these deficits, research has
focused on the limbic system and, in particular, on the
amygdala [3]. It has been repeatedly shown that the amyg-
dala is crucially involved in the perception of facial emo-
tions [4]. Findings from neuroimaging studies on the
amygdala response to facial expression in schizophrenia
are heterogeneous and strongly dependent on experimen-
tal design. Some authors have found that patients show re-
duced activation of the amygdala in response to emotional
face stimuli, which could be interpreted as an impairment
in the processing of affective information [5,6]. On the
other hand, others have shown normal activation or even
hyperactivation of the amygdala, indicating that patients
may suffer from hypersensitivity to emotional faces [7-9].
Thus far, only a few studies have investigated the auto-
matic processing of facial emotion and its neural corre-
lates in schizophrenia. This is surprising because
emotional reactions are generally elicited involuntarily
and emerge without conscious effort [10]. Two behav-
ioral studies have examined the effect of masked facial
emotion on evaluation processes using an affective prim-
ing paradigm [11]. Affective priming paradigms can be
applied to examine whether facial emotional expression
presented outside of conscious awareness colors evalu-
ative judgments. Typically, neutral stimuli preceded by
subliminally shown happy faces are evaluated more posi-
tively than those preceded by subliminally shown neutral
faces. Neutral stimuli preceded by subliminally presented
angry faces are evaluated more negatively than those
preceded by subliminally presented neutral faces [11].
This phenomenon of an affective influence of emotional
facial expression on subsequent judgments is termed the
affective priming effect. Höschel and Irle [12] were the
first to demonstrate that schizophrenia patients exhibit a
stronger negative evaluative bias in response to covert
negative facial expression (i.e., more negative affective
priming) than healthy controls. Extending these findings,
Suslow et al. [13] observed that schizophrenia patients suf-
fering from affective negative symptoms (i.e., anhedonia or
flat affect) were particularly sensitive to negative facial ex-
pressions on an automatic processing level. It was con-
cluded that social withdrawal and symptoms of flat affect in
schizophrenia might develop as self-protective mechanisms
to reduce aversive stimulation during social interactions.
To our knowledge, only two neuroimaging studies
have examined the automatic processing of facial emo-
tion in schizophrenia. According to the results of Das
et al. [14], schizophrenia patients show reduced activityin the bilateral amygdala during perception of masked
fearful faces (relative to neutral faces) compared to
healthy controls. The observed amygdala hypoactivation
could be due to the baseline condition used (i.e., neutral
faces) because previous research indicates that schizo-
phrenia patients exhibit increased activation of the
amygdala to neutral facial expressions [15]. In a subse-
quent fMRI study [16], schizophrenia patients showed
stronger activation of the amygdala in response to sad
and happy faces than did healthy controls. However, the
effects were quite small, potentially due to the small
sample sizes studied (N = 12 for patients and controls).
Because previous findings regarding the automatic
amygdala response to facial emotion have been incon-
sistent, further research on this issue is required. The
first aim of the present study was to examine whether
schizophrenia patients manifest amygdala hyperactiva-
tion to facial expression at an automatic processing level.
Automaticity of processing can be assumed when pro-
cessing occurs rapidly, unintentionally, and with no or
minimal attention [17]. In our fMRI experiment, we pre-
sented angry, happy, and neutral faces as stimuli only
very briefly; these were subsequently masked by neutral
faces. We used no facial expression stimuli as the base-
line condition because schizophrenia patients have pre-
viously demonstrated increased amygdala responses to
neutral faces [3,15].
Our second aim was to investigate the time-course of
the neural processing of facial emotion. It has been
shown that affective priming with masked emotio-
nal faces emerges strongly in initial presentations but
decreases rapidly with repetition [18]. Moreover, it is
well established that the amygdala response habituates
(i.e., decreases over time) to repeated presentations of fa-
cial expressions [19,20]. Finally, it has been observed that
patients with schizophrenia show similar or higher amyg-
dala activation in response to facial emotions during the
initial stage of processing than healthy controls but that
the activation in patients appears to decrease more strongly
with repetition [9,15]. Thus, there are several reasons to
investigate the automatic processing of facial emotion as a
function of time in both schizophrenia patients and
healthy individuals. According to Holt and Phillips [21],
there is the possibility that changes in brain function during
emotional processing in schizophrenia are dynamic in na-
ture, with an initial hyperresponsivity followed by hypore-
sponsivity of medial temporal lobe structures, including the
amygdala. To investigate the time-course of automatic
emotion processing, our fMRI priming experiment was
split into two phases of equal length in which identical fa-
cial stimuli were displayed.
We hypothesized that compared to controls, patients
would initially manifest heightened amygdala activation
in response to all facial expressions (versus no facial
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nia patients and controls would show stronger amygdala
activation to angry, happy, and neutral faces during the
initial phase than during the second phase of the experi-
ment. Third, we hypothesized that amygdala deactivation
from the initial to the second phase would be more pro-
nounced for patients than controls.
Results
Behavioral results
Table 1 shows mean evaluative ratings and affective prim-
ing scores of patients and controls for all priming condi-
tions during both phases of the experiment. According to
the results from the 2*2*3 ANOVA, there was no signifi-
cant effect of group (F(1,63) = 0.039, p = 0.844) or phase
(F(1,63) = 0.001, p = 0.975), but the effect of condition was
significant (F(2,126) = 6.158, p = 0.003). The interactions
between condition and group (F(2,126) = 1.497, p = 0.228)
and between phase and group (F(1,63) = 0.025, p = 0.667)
were not significant, but we observed a significant inter-
action between phase and condition (F(2,126) = 10.095,
p < 0.001) and a significant group*phase*condition inter-
action (F(2,126) = 3.290, p = 0.041).
Subsequently, 2 (group)*2 (phase) ANOVAs were con-
ducted for all affective priming conditions (i.e., angry,
happy, and neutral). The results from the 2*2 ANOVATable 1 Mean evaluative ratings and affective priming
scores of patients and controls during the initial phase
and second phase of the experiment (patients: N = 30;
controls: N = 35); mean ± SE; range of evaluative ratings:
-1.5 to +1.5; affective priming score: difference between




No facial expression Initial 0.00 ± 0.27 −0.07 ± 0.28
Second 0.13 ± 0.33 0.02 ± 0.26
Neutral Initial −0.04 ± 0.25 −0.06 ± 0.21
Second −0.05 ± 0.27 −0.04 ± 0.25
Angry Initial −0.17 ± 0.24 −0.12 ± 0.24
Second −0.11 ± 0.30 −0.02 ± 0.27
Happy Initial 0.01 ± 0.28 −0.09 ± 0.25
Second 0.14 ± 0.31 0.02 ± 0.27
Affective priming scores
Neutral Initial 0.04 ± 0.34 0.01 ± 0.25
Second −0.08 ± 0.34 −0.06 ± 0.15
Angry Initial −0.17 ± 0.32 −0.05 ± 0.20
Second −0.01 ± 0.28 −0.04 ± 0.17
Happy Initial 0.00 ± 0.31 −0.02 ± 0.20
Second 0.01 ± 0.22 0.00 ± 0.14for angry primes indicated a significant effect of phase (F
(1,63) = 4.487, p = 0.038), as mean evaluative ratings were
more positive during the second phase. The main effect
of group was not significant (F(1,63) = 1.008, p = 0.319)
but the interaction between phase and group was close
to significance (F(1,63) = 3.495, p = 0.066). According to
the results from independent two sample t-tests, nega-
tive priming for masked angry faces tended to be stron-
ger in patients than in controls during the initial phase
(t = −1.77, df = 63, p = 0.083) but was similar during the
second phase (t = 0.50, df = 63, p = 0.622).
According to the results from the 2 (group)*2 (phase)
ANOVA for happy primes, there were no significant
effects of phase (F(1,63) = 0.106, p = 0.746) or group
(F(1,63) = 0.281, p = 0.598) nor was there a significant
group*phase interaction (F(1,63) = 0.027, p = 0.871).
The results from the 2 (group)*2 (phase) ANOVA for
neutral primes indicated a marginally significant effect of
phase (F(1,63) = 3.714, p = 0.058). Priming scores for neu-
tral faces were more negative during the second phase
compared to the initial phase. Neither the effect of group
(F(1,63) = 0.009, p = 0.925) nor the interaction between
phase and group (F(1,63) = 0.176, p = 0.676) were significant.
fMRI results
Full factorial ANOVA model: group*phase*condition
The results from the 2 (group: schizophrenia patients and
healthy controls)*2 (phase: first and second half)*3 (condi-
tion: angry, happy, and neutral) full factorial ANOVA re-
vealed no effect of group on amygdala activation. The effect
of phase on amygdala activation was significant (left peak
voxel xyz: -20 -4 -20, cluster size: 128, F(1,378) = 28.11,
Z-score = 5.07, p = 0.0000002; right peak voxel xyz: 22
0–20, cluster size: 104, F(1,378) = 12.81, Z-score = 3.36,
p =0.0004), indicating that amygdala activation was larger
during the initial phase than in the second phase. Condition
showed an effect on right amygdala activation (peak voxel
xyz: 24–4 -18, cluster size: 45, F(2,378) = 6.81, Z-score =
3.02, p = 0.001). The group*condition and phase*condition
interaction effects on amygdala activation were not signifi-
cant, but the interaction between group and phase was sig-
nificant (left peak voxel xyz: -26 -2 -12, cluster size: 75,
F(1,378) = 12.02, Z-score = 3.24, p = 0.0006; right peak voxel
xyz: 26–4 -14, cluster size: 81, F(1,378) = 18.37, Z-score =
4.07, p = 0.00002). Furthermore, the group*phase*condition
interaction effect was significant for the left amygdala (peak
voxel xyz: -28 -6 -14, cluster size: 58, F(2,378) = 9.75,
Z-score = 3.79, p = 0.00008).
Post-hoc analyses
Activation of the left amygdala in response to angry faces
as a function of group and phase
Results from a 2 (group)*2 (phase) ANOVA indicate a
significant effect of phase on left amygdala activation,
Figure 1 Schizophrenia patients manifest increased right
amygdala response to faces (versus no facial expression)
compared to healthy controls during the first phase of the
experiment (A) and healthy subjects show increased right
amygdala activation in response to faces compared to patients
during the second phase (B). Blood oxygenation level-dependent
responses are superimposed on MNI standard brain template.
Coordinates in the reference frame of MNI space. Color bar: t-values.
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of the experiment (peak voxel xyz: -20 -6 -18, cluster size:
114, F(1,126) = 28.17, Z-score = 4.90, p = 0.0000005).
Group status had no significant main effect on amygdala
activation but the interaction between group and experi-
mental phase on left amygdala activation was highly sig-
nificant (peak voxel xyz: -24 -2 -14, cluster size: 97,
F(1,126) = 19.26, Z-score = 4.07, p = 0.00002).
Subsequent post-hoc t-tests showed that controls
manifested higher left amygdala activation during the
second (but not the first) phase of the experiment than
patients (peak voxel xyz: -24 -4 -16, cluster size: 118,
t(63) = 4.40, Z-score = 4.09, p = 0.00004). Patients exhib-
ited no stronger activation than controls in response to
angry faces.
Activation of the left amygdala in response to happy faces
as a function of group and phase
A group*phase ANOVA revealed a significant effect of
phase on left amygdala activation (peak voxel xyz: -20 -4
-18, cluster size: 111, F(1,126) = 29.49, Z-score = 5.01,
p = 0.0000003), indicating that the left amygdala re-
sponse to happy faces was larger in the initial phase than
in the second phase. Group status had no significant ef-
fect on amygdala activation, and the interaction between
group and phase was also not significant.
Activation of the left amygdala in response to neutral faces
as a function of group and phase
A group*phase ANOVA again revealed a significant effect
of phase on left amygdala activation (peak voxel xyz: -24
2–16, cluster size: 67, F(1,126) = 10.80, Z-score = 3.01, p =
0.001). Group status had no significant effect on left amyg-
dala activation, but the interaction between group and
phase was significant (peak voxel xyz: -26 -2 -12, cluster
size: 51, F(1,126) = 11.30, Z-score = 3.08, p = 0.001).
Subsequent post-hoc t-tests showed that patients ex-
hibited left amygdala hyperactivation in response to neu-
tral faces during the initial phase, compared to healthy
controls (peak voxel xyz: -24 0–14, cluster size: 52, t(63)
= 3.16, Z-score = 3.04, p = 0.001). During the second
phase, no significant difference in left amygdala activa-
tion between patients and controls emerged.
Activation of the right amygdala in response to all faces as
a function of group and phase
To clarify the group*phase interaction effect, we com-
pared the right amygdala response to all faces (angry,
happy, and neutral) between groups for both phases of
the experiment (see Figure 1). In the initial phase, pa-
tients manifested stronger amygdala activation to faces
than did controls (peak voxel xyz: 30–2 -12, cluster size:
68, t(63) = 2.65, Z-score = 2.63, p = 0.004). In the second
phase, healthy participants manifested stronger amygdalaactivation to faces than patients (peak voxel xyz: 26–6
-14, cluster size: 55, t(63) = 4.03, Z-score = 3.98, p =
0.00007).
Discussion
The present study revealed new insights into abnormal-
ities in the perception of facial emotion at an automatic
processing level in schizophrenia patients. None of the
participants included in our analyses had subjective
awareness of emotional primes. Therefore, the emotional
expression in prime faces was most likely processed
automatically, without time for overt attention. As hy-
pothesized, in response to angry, happy, and neutral
faces versus no facial expression primes, we observed in-
creased right amygdala activation in schizophrenia pa-
tients compared to healthy controls during the initial
phase. For the left amygdala, we found a heightened re-
sponse in patients only to neutral faces compared to
controls. These results are consistent with those of
Rauch et al. [16] and indicate a stronger automatic
amygdala response to facial expression in schizophrenia.
Initial hyperactivation of the amygdala in schizophrenia
may indicate greater automatic encoding and an in-
creased allocation of resources for processing facial ex-
pressions. It is well known that the amygdala modulates
vigilance to enhance subsequent information processing
throughout the brain [22], such that it represents an in-
tegral part of a cerebral network for unconscious emo-
tional vigilance [23].
As hypothesized, patients showed an initial bilateral
amygdala hyperresponsivity to masked neutral faces
compared to healthy controls. Several previous studies
have demonstrated that schizophrenia patients exhibit
amygdala hyperactivation to neutral faces in paradigms
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ings suggest that this potential neural correlate of a
generalized “fear of faces” [25] also emerges under auto-
matic processing conditions. Therefore, previous results
in studies using neutral faces as a baseline condition
may be distorted [3,15]. Against this background, it is
not surprising that Das et al. [14], who used neutral
faces as a baseline, observed amygdala hypoactivation to
masked fearful faces in schizophrenia patients compared
to healthy controls.
Our hypothesis that amygdala activation in response
to all facial primes would be reduced in the second com-
pared to the first phase of the experiment was confirmed
by the observed main effect of phase. These effects of
time could be due to habituation upon the second pres-
entation of the stimuli. Repetition suppression has previ-
ously been observed in the amygdala for subliminally
presented facial emotions [26], and repetition-related re-
ductions in amygdala responses to emotional stimuli
have been demonstrated [19,20,27]. According to our
data, the amygdala response to facial expressions rapidly
habituates, even when faces are presented outside of
subjects’ conscious awareness.
Our fMRI results corroborate the hypothesis that
schizophrenia patients manifest a stronger decrease in
the (right) amygdala response to facial stimuli over time
than healthy individuals. During the first phase, patients
showed stronger activation of the amygdala in response
to faces than did controls, whereas in the second phase
of the experiment, healthy individuals manifested stron-
ger amygdala activation than patients. The decreases in
amygdala activation observed in patients can be viewed
in the context of their high levels of initial activation.
The mechanisms underlying these effects of repetition
and time may reflect an initial hypersensitivity to facial
emotions and a subsequent down-regulation of activity.
It appears that the processing of emotional faces is auto-
matically suppressed over time in patients. This suppres-
sion could represent a compensatory mechanism for
initial limbic hypersensitivity. The switch of patients
from amygdala hyperactivation to hypoactivation (com-
pared to healthy subjects) might reflect inhibitory pro-
cesses. Blocking of amygdala responsivity might protect
schizophrenia patients from overstimulation during so-
cial interactions.
Our findings on the automatic processing of emotional
faces are consistent with observations from research on
controlled emotion processing in schizophrenia. Accord-
ing to Holt et al. [15] and Salgado-Pineda et al. [9],
schizophrenia patients exhibit amygdala activation that
is similar or higher than in healthy individuals during
the first stage of processing emotional information, and
this activation subsequently diminishes more strongly
than in healthy controls. Our data are in agreement withthe assumption of Holt and Phillips [21] that emotional
processing in schizophrenia could be characterized by
an initial hyperresponsivity followed by hyporesponsivity
of medial temporal lobe structures such as the amygdala.
To draw stronger conclusions, our finding of a switch
from amygdala hyperactivation to hypoactivation in schizo-
phrenia should be replicated. Further studies should exam-
ine the time-course of limbic activation during automatic
as well as controlled processing of emotionally relevant
stimuli in more detail. In addition, re-analyses of prior
studies with a focus on time-course could provide valuable
information. In particular, studies reporting amygdala
under-recruitment during emotional face processing
should be reconsidered [5,28], as their results might be
explained at least in part by the occurrence of suppres-
sion processes over time.
According to our behavioral data, patients’ ratings
were negatively biased by angry facial expressions. In the
initial phase, patients’ evaluative ratings of neutral mask
faces tended to be more negative when preceded by
angry faces than when preceded by no facial expression
primes, compared to healthy individuals. These findings
corroborate previous results from affective priming stud-
ies, suggesting that schizophrenia patients exhibit a
stronger negative evaluative bias in response to covert
negative facial expressions than do healthy individuals
[12,13]. The fact that affective priming due to masked
angry faces decreased from the first to the second phase,
independently of group, substantiates previous findings on
the time-course of affective priming, with strong effects of
masked emotional faces in initial presentations followed
by substantial decreases in priming with repetition [18].
Some limitations of our study need to be acknowl-
edged. First, our operationalization of time-course by
dividing the experiment into two equivalent halves, with
prime stimulus repetition between halves, was rather
coarse. We analyzed ten events per condition and phase,
but amygdala blocking might occur even earlier, possibly
after only two or three presentations. More fine-grained
experimental designs and time-sensitive methods such
as EEG-informed fMRI might help uncover precisely
when blocking processes begin. All patients in our study
received atypical antipsychotics. Future research must
clarify the effects of antipsychotic medication on the time-
course of activation of the amygdala during emotional face
processing. There is evidence from longitudinal fMRI re-
search that treatment with atypical antipsychotics is asso-
ciated with a reduction of the amygdala response during
emotional processing in schizophrenia [29]. Against this
background, antipsychotic medication in our sample could
have counteracted the initial hyperresponsiveness effects
observed in the patients in our study, which might there-
fore be even stronger in unmedicated patients. Further-
more, our sample size was too small to warrant subgroup
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toms. A promising future direction may be to compare
the neural underpinnings of automatic emotion processing
in patient groups suffering primarily from anhedonia,
affective flattening, or paranoid ideation. A plausible hy-
pothesis is that the initial amygdala hyperactivation is
most pronounced in patients suffering predominantly
from positive symptoms such as persecutory delusions.
Moreover, one could assume that the observed blocking of
the amygdala response might be strongest in patients exhi-
biting severe affective negative symptoms.
Conclusion
In the present study, we investigated amygdala responses
to facial expression at an automatic processing level in
schizophrenia. To examine the time-course of automatic
emotion processing, our fMRI priming experiment was
split into two halves, in which identical facial expres-
sions were presented. As hypothesized, across priming
conditions and groups, we observed a reduction of
amygdala activation during the second compared to the
first phase of the experiment. Schizophrenia patients are
characterized by high initial amygdala responsivity to fa-
cial expression at an automatic processing level, which
substantially diminishes over time. High initial activation
of the amygdala to faces in schizophrenia could indicate
a greater degree of automatic encoding and increased al-
location of resources to processing these social stimuli.
Amygdala deactivation over time might reflect an auto-
matic mechanism by which schizophrenia patients sup-
press the processing of facial stimuli. This blocking
mechanism could help patients avoid overstimulation
during face-to-face contact. Finally, compared to healthy
individuals, schizophrenia patients manifested initially
enhanced bilateral amygdala responses to faces with
neutral expression. Schizophrenia patients may perceive
neutral facial expressions as ambiguous social cues, and
the use of neutral faces as a baseline condition may
therefore be inadequate for future neuroimaging re-




The original sample included 36 schizophrenia patients
and 42 healthy controls, aged between 18 and 55 years.
For all participants, exclusion criteria were a history of
neurological disease, severe head trauma causing loss of
consciousness, substance abuse during the last six months,
and the usual magnetic resonance imaging contraindica-
tions. All subjects had normal or corrected-to-normal
vision. Control subjects were thoroughly investigated by
trained psychologists and were free of any lifetime history
of psychiatric disorders, as diagnosed with the StructuredClinical Interview for DSM-IV, Axis I disorders [29]. Pa-
tients’ diagnoses were established by senior psychiatrists
and confirmed by trained interviewers with the Structured
Clinical Interview for DSM-IV [30]. During the patient
interview, special attention was given to affective disorders
to exclude a current depressive episode in study patients. In
addition, all patients were administered a structured proto-
col of the Scale for the Assessment of Negative Symptoms
(SANS) [31] and the Scale for the Assessment of Positive
Symptoms (SAPS) [32]. For all participants, depressive
symptoms were measured with the Beck Depression
Inventory (BDI) [33]. Verbal intelligence was estimated
by the Mehrfachwahl–Wortschatz–Intelligenztest (Multiple-
Choice–Vocabulary–Intelligence Test; MWT-B) [34].
Five patients and six controls had to be excluded due
to excessive movement during the functional scans or
due to technical problems with the response boxes. One
patient and one control subject had to be excluded be-
cause they reported (subjective) awareness of the primes,
leaving a final sample of 30 patients and 35 controls.
Table 2 lists sociodemographic and questionnaire data of
the included participants and clinical data for patients.
All 30 patients received second-generation antipsychotics,
and three received additional typical antipsychotics. Thir-
teen patients were taking concomitant antidepressant
medication, three were taking anticonvulsants, and one
was taking lithium.
The study was conducted in accordance with the Dec-
laration of Helsinki as revised in 1989 and was approved
by the Ethics Committee of the University of Münster.
After a complete description of the study, written in-
formed consent was obtained. Patients received a financial
compensation of 50 €, and controls received 40 €.
Experimental design
Participants viewed gray-scale normalized face stimuli
that were selected from a standardized picture set [35].
Ten pictures of neutral facial expressions (5 male and 5
female) were used as target stimuli. Prime stimuli were
pictures of the same actors showing angry, happy, and
neutral facial expressions. To avoid identity of prime
and mask in the neutral face condition, neutral primes
were vertically mirrored. As a baseline condition, we
used no facial expression prime stimuli, consisting of
neutral faces in which central facial features (i.e., eyes,
nose, and mouth) had been replaced by a surface with-
out contours (see Figure 2 for examples of the four
prime conditions). Each trial lasted for 9 seconds. A fix-
ation cross presented for 800 ms preceded a prime face
shown for 33 ms, followed by the corresponding neutral
face mask for 467 ms. A blank screen followed for
7.7 seconds (see Figure 3). Subjects were instructed to
evaluate whether the neutral (mask) faces expressed
Table 2 Sociodemographic, handedness, intelligence,
and affectivity data of patients (N = 30) and controls
(N = 35), and clinical data for patients; mean ± SD (range);
p: significance of two sample t-test (or chi-square test)
comparing patients and controls
Patients Controls p
Age 30.9 ± 7.6 (18–51) 29.6 ± 8.4 (19–49) 0.515
Education years 13.3 ± 2.4 (9–18) 14.6 ± 2.4 (9–18) 0.041*
Parental education years1 14.6 ± 2.8 (10–18) 14.9 ± 2.7 (11–18) 0.74
Sex (m/f) 17/13 23/12 0.61
Handedness (right/left) 29/1 33/2 1.000
Verbal intelligence2 108.1 ± 14.2 (88–
136)
112.5 ± 11.9 (95–
136)
0.17
BDI 12.5 ± 7.2 (0–28) 2.1 ± 2.8 (0–10) <0.001*
STAI-T 47.4 ± 9.0 (25–71) 29.9 ± 6.5 (22–45) <0.001*
SANS3 – flat affect 2.2 ± 1.2 (0–5)
SANS – alogia 1.8 ± 1.0 (0–4)
SANS – apathy 2.1 ± 0.6 (1–3)
SANS – anhedonia 2.0 ± 1.0 (0–4)
SANS – attention 1.9 ± 0.7 (0–3)
SAPS – hallucinations 0.3 ± 0.5 (0–2)
SAPS – delusions 1.2 ± 0.8 (0–3)
SAPS – bizarre behavior 0.7 ± 0.8 (0–2)
SAPS – formal thought
disorders
1.8 ± 1.1 (0–4)
Years of illness 6.7 ± 5.7 (0.5-19.0)
1Years of education of the parent with the highest degree. Data missing for
two patients.
2Assessed with the Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B [33]).
3All SANS and SAPS scores represent global ratings of the symptom.
*p < .05 (two-tailed).
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one of four buttons (− 1.5, − 0.5, + 0.5, and + 1.5). Judg-
ments and reaction times were registered.
The paradigm consisted of two experimental phases,
each with 40 trials: 10 with angry, 10 with happy, 10
with neutral, and 10 with no facial expression primes. In
both phases, we used stimuli of the same ten actors,
which were presented in a pseudo-randomized order.Figure 2 Examples of faces presented in the four prime conditions (hThe transition from the initial phase (first half ) to the
second phase (second half ) was not marked. The experi-
ment lasted 12 min. Thus, our paradigm was a repetition
priming paradigm with 40 stimuli presented in the first
half of the experiment and the same 40 stimuli pre-
sented in the second half of the experiment. Stimuli
were shown in a fixed pseudo-random order format.
That means that randomization was implemented with
the restriction of no repetition of an individual (taken
from the Pictures of Facial Affect [35]) and no more
than one repetition of a prime condition (angry, happy,
neutral, or no facial expression) on consecutive trials.
To assess the success of masking, subjects were ques-
tioned after the experiment as to whether they had no-
ticed anything out of the ordinary, and whether they had
seen anything just before the neutral target faces. None
of the participants included in the subsequent statistical
analyses reported noticing emotional facial expressions
prior to presentation of the neutral faces.
Behavioral affective priming scores were calculated by
subtracting the mean evaluation score for the no facial
expression prime condition from the mean evaluation
scores for angry, happy, and neutral prime stimuli. Thus,
negative scores indicate a negative evaluative bias and
positive scores indicate a positive evaluative bias. Data
were analyzed with a 2 (group)*2 (phase)*3 (condition)
ANOVA using SPSS (IBM, Armonk, New York). Group
(patients versus controls) was a between-subjects factor,
and phase (initial versus second) and condition (angry
versus happy versus neutral) were within-subjects fac-
tors. To overcome violations of sphericity in the data,
the Greenhouse-Geisser statistic is reported for repeated-
measures effects.
fMRI methods
Images were projected to the rear end of the scanner
(SharpXG-PC10XE with additional high frequency shield-
ing; Osaka, Japan). T2* functional data were acquired in a
3-Tesla scanner (Gyroscan Intera 3.0 T, Philips Medical
Systems, Best, NL) using a single shot echoplanar se-
quence, with parameters selected to minimize distortionappy, angry, neutral, and no facial expression).
Figure 3 Sequence of events within trials of the fMRI experiment. Subjects had to evaluate the neutral mask face as expressing negative or
positive feelings by pressing one of four buttons. In our example, a trial with an angry prime is shown.
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http://www.biomedcentral.com/1471-2202/14/140in the regions of central interest while retaining adequate
S/N and T2* sensitivity. Volumes consisting of 36 axial
slices were acquired (matrix 64 * 63, resolution 3.6 * 3.6 *
3.5 mm; repetition time = 2.5 s, echo time = 35 ms, flip
angle = 90°) 288 times in a slow event-related design.
Functional imaging data were motion-corrected using
a set of six rigid body transformations determined for
each image, spatially normalized to standard MNI space
(Montreal Neurological Institute) with a voxel size of 2 *
2 * 2 mm and smoothed (Gaussian kernel, 8 mm
FWHM) using Statistical Parametric Mapping (SPM5,
Wellcome Department of Cognitive Neurology, London,
UK). Statistical analysis was performed by modeling the
different perceptual conditions (angry, happy, neutral,
no facial expression) as variables within the context of
the general linear model convolved with a standard
hemodynamic response function. Fixed-effects analyses
were performed at the individual level to generate indi-
vidual contrast maps, and random effects analyses were
performed at the group level. On a single subject level,
contrast images were calculated for each of the two
phases comparing each facial expression condition
(angry, happy, neutral) with the no facial expression
baseline condition, resulting in six contrast maps.
Second-level fMRI analysis
Standard univariate group-level statistics were con-
ducted using SPM5. For all analyses, the amygdala was
chosen as the a priori region of interest (ROI). The
amygdala was defined according to Tzourio-Mazoyer
et al. [36], and the amygdala mask was created by means
of the WFU PickAtlas [37]. To control for multiple stat-
istical testing, we maintained a cluster-level false-
positive detection rate at p < 0.05 using an uncorrected
voxel threshold of p < 0.05 with a cluster extent (k Vox-
els) empirically determined by Monte Carlo Simulations
(N = 1000 iterations) for the bilateral amygdala. This was
performed by means of the AlphaSim procedure, which
accounts for spatial correlations between BOLD signal
changes in neighboring voxels implemented in the RESTtoolbox (http://restfmri.net/forum/index.php), yielding
an empirically determined cluster threshold of k = 37
voxels.
Second-level fMRI data analyses were performed using
SPM5. First, we computed a 2*2*3 full factorial ANOVA
model with one between-subjects factor (group: patients
versus controls) and two within-subjects factors (phase
(first phase versus second phase) and condition (angry
versus happy versus neutral face)) for the bilateral amyg-
dala. Next, to clarify the significant group*phase*condi-
tion interaction found for the left amygdala, we
computed separate 2 (group)*2 (phase) ANOVAs for
each of the three facial expression conditions (i.e., angry,
happy, and neutral). If required, t-tests for independent
samples were subsequently applied to compare amygdala
activation between groups for specific facial conditions
and phases. Finally, to further analyze the significant
group*phase interaction found in the initial ANOVA for
the right amygdala, we compared activation of the right
amygdala between groups in the initial and then in the
second phase on all facial expression conditions by mod-
eling the relevant between-group contrasts (all faces vs.
no facial expression).
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